DABIGATRANUM ETEXILATUM
39 medicamente autorizate în România conțin substanța activă DABIGATRANUM ETEXILATUM.
| Denumire comercială | Concentrație | Formă farmaceutică | Producător | Cod ATC | Prospect |
|---|---|---|---|---|---|
| DABIGATRAN ETEXILAT DR. REDDY'S 110 mg | 110mg | CAPS. | BETAPHARM ARZNEIMITTEL GMBH - GERMANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT DR. REDDY'S 150 mg | 150mg | CAPS. | BETAPHARM ARZNEIMITTEL GMBH - GERMANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT DR. REDDY'S 75 mg | 75mg | CAPS. | BETAPHARM ARZNEIMITTEL GMBH - GERMANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | 110mg | CAPS. | LABORATORIOS LICONSA, S.A. - SPANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 150 mg | 150mg | CAPS. | LABORATORIOS LICONSA, S.A. - SPANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 75 mg | 75mg | CAPS. | LABORATORIOS LICONSA, S.A. - SPANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT LICONSA 110 mg | 110mg | CAPS. | LABORATORIOS LICONSA, S.A. - SPANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT LICONSA 150 mg | 150mg | CAPS. | LABORATORIOS LICONSA, S.A. - SPANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT LICONSA 75 mg | 75mg | CAPS. | LABORATORIOS LICONSA, S.A. - SPANIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT VIATRIS 110 mg | 110mg | CAPS. | MYLAN HUNGARY KFT. - UNGARIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT VIATRIS 150 mg | 150mg | CAPS. | MYLAN HUNGARY KFT. - UNGARIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILAT VIATRIS 75 mg | 75mg | CAPS. | MYLAN HUNGARY KFT. - UNGARIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILATE ACCORD 110 mg | 110mg | CAPS. | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILATE ACCORD 150 mg | 150mg | CAPS. | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | B01AE07 | 📄 Prospect |
| DABIGATRAN ETEXILATE ACCORD 75 mg | 75mg | CAPS. | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | B01AE07 | 📄 Prospect |
| DAROXOMB 110 mg | 110mg | CAPS. | GALENICUM HEALTH, S.L.U. - SPANIA | B01AE07 | 📄 Prospect |
| DAROXOMB 150 mg | 150mg | CAPS. | GALENICUM HEALTH, S.L.U. - SPANIA | B01AE07 | 📄 Prospect |
| DAROXOMB 75 mg | 75mg | CAPS. | GALENICUM HEALTH, S.L.U. - SPANIA | B01AE07 | 📄 Prospect |
| DAXANLO 110 mg | 110mg | CAPS. | KRKA, D.D., NOVO MESTO - SLOVENIA | B01AE07 | 📄 Prospect |
| DAXANLO 150 mg | 150mg | CAPS. | KRKA, D.D., NOVO MESTO - SLOVENIA | B01AE07 | 📄 Prospect |
| DAXANLO 75 mg | 75mg | CAPS. | KRKA, D.D., NOVO MESTO - SLOVENIA | B01AE07 | 📄 Prospect |
| GRIBERO 110 mg | 110mg | CAPS. | PHARMADOX HEALTHCARE LTD. - MALTA | B01AE07 | 📄 Prospect |
| GRIBERO 150 mg | 150mg | CAPS. | PHARMADOX HEALTHCARE LTD. - MALTA | B01AE07 | 📄 Prospect |
| GRIBERO 75 mg | 75mg | CAPS. | PHARMADOX HEALTHCARE LTD. - MALTA | B01AE07 | 📄 Prospect |
| PRADAXA 110 mg | 110mg | GRANULE DRAJEFIATE | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 110mg | 110mg | CAPS. | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 150 mg | 150mg | GRANULE DRAJEFIATE | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 150mg | 150mg | CAPS. | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 20 mg | 20mg | GRANULE DRAJEFIATE | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 30 mg | 30mg | GRANULE DRAJEFIATE | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 40 mg | 40mg | GRANULE DRAJEFIATE | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 50 mg | 50mg | GRANULE DRAJEFIATE | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 6,25 mg/ml | 6,25mg/ml | PULB. + SOLV. PT. SOL. ORALA | CATALENT GERMANY SCHORNDORF GMBH - GERMANIA | B01AE07 | 📄 Prospect |
| PRADAXA 75mg | 75mg | CAPS. | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA | B01AE07 | 📄 Prospect |
| TELEXER 110 mg | 110mg | CAPS. | GEDEON RICHTER POLSKA SP. Z O.O. - POLONIA | B01AE07 | 📄 Prospect |
| TELEXER 150 mg | 150mg | CAPS. | GEDEON RICHTER POLSKA SP. Z O.O. - POLONIA | B01AE07 | 📄 Prospect |
| WASEDOC 110 mg | 110mg | CAPS. | TOWA PHARMACEUTICAL EUROPE S.L. - SPANIA | B01AE07 | 📄 Prospect |
| WASEDOC 150 mg | 150mg | CAPS. | TOWA PHARMACEUTICAL EUROPE S.L. - SPANIA | B01AE07 | 📄 Prospect |
| WASEDOC 75 mg | 75mg | CAPS. | TOWA PHARMACEUTICAL EUROPE S.L. - SPANIA | B01AE07 | 📄 Prospect |